Chilton Investment Co. LLC Has $10.89 Million Stake in Thermo Fisher Scientific Inc (TMO)

Chilton Investment Co. LLC cut its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 45.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 62,409 shares of the medical research company’s stock after selling 52,699 shares during the quarter. Chilton Investment Co. LLC’s holdings in Thermo Fisher Scientific were worth $10,888,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Thermo Fisher Scientific by 0.4% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,065 shares of the medical research company’s stock valued at $5,071,000 after purchasing an additional 106 shares during the period. Pictet North America Advisors SA boosted its stake in shares of Thermo Fisher Scientific by 2.8% in the second quarter. Pictet North America Advisors SA now owns 1,764 shares of the medical research company’s stock valued at $308,000 after purchasing an additional 48 shares during the period. Sphera Funds Management LTD. boosted its stake in shares of Thermo Fisher Scientific by 69.1% in the second quarter. Sphera Funds Management LTD. now owns 11,688 shares of the medical research company’s stock valued at $2,039,000 after purchasing an additional 4,775 shares during the period. State of Tennessee Treasury Department boosted its stake in shares of Thermo Fisher Scientific by 16.3% in the second quarter. State of Tennessee Treasury Department now owns 345,581 shares of the medical research company’s stock valued at $60,294,000 after purchasing an additional 48,462 shares during the period. Finally, Cedar Capital LLC purchased a new position in shares of Thermo Fisher Scientific in the second quarter valued at $230,000. Institutional investors and hedge funds own 83.36% of the company’s stock.

Several research analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, September 18th. Jefferies Group LLC restated a “hold” rating and issued a $195.00 target price on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Wells Fargo & Company restated an “outperform” rating and issued a $200.00 target price (up from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. Bank of America Corporation restated a “buy” rating and issued a $210.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Finally, Cleveland Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. One analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $203.64.

In other Thermo Fisher Scientific news, VP Peter E. Hornstra sold 3,894 shares of Thermo Fisher Scientific stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the sale, the vice president now owns 19,751 shares in the company, valued at $3,657,490.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jim P. Manzi sold 11,318 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the sale, the director now owns 38,757 shares in the company, valued at approximately $6,702,635.58. The disclosure for this sale can be found here. Insiders have sold 52,738 shares of company stock worth $9,302,112 in the last ninety days. 0.49% of the stock is currently owned by insiders.

Thermo Fisher Scientific Inc (TMO) opened at 192.64 on Wednesday. The firm’s 50-day moving average is $187.80 and its 200-day moving average is $174.71. The company has a market capitalization of $75.15 billion, a P/E ratio of 33.56 and a beta of 1.05. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same quarter in the previous year, the firm posted $2.03 earnings per share. Thermo Fisher Scientific’s revenue was up 10.2% compared to the same quarter last year. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

WARNING: “Chilton Investment Co. LLC Has $10.89 Million Stake in Thermo Fisher Scientific Inc (TMO)” was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://stocknewstimes.com/2017/10/11/chilton-investment-co-llc-has-10-89-million-stake-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply